<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04815525</url>
  </required_header>
  <id_info>
    <org_study_id>2020.597</org_study_id>
    <nct_id>NCT04815525</nct_id>
  </id_info>
  <brief_title>The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong Kong</brief_title>
  <acronym>ACNC</acronym>
  <official_title>The Longterm Risk of Advanced Colorectal Neoplasia After Colonoscopy - A Population-based Cohort Study in Hong Kong</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to analyze the 15-year cumulative incidence of&#xD;
      advanced colorectal neoplasia and CRC-related mortality after the index colonoscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a territory-wide retrospective observational cohort study using the Clinical Data&#xD;
      Analysis and Reporting System (CDARS). We will identify patients from CDARS with colonoscopy&#xD;
      performed from 1 January 2000 to 31 October 2020. Other relevant diagnoses, procedures,&#xD;
      concomitant drugs, laboratory parameters and pathology results will be retrieved and studied.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 15, 2021</start_date>
  <completion_date type="Anticipated">June 7, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 7, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Culumative incidence of advanced colorectal neoplasia</measure>
    <time_frame>15 years</time_frame>
    <description>high-risk adenomas or CRC after 15 years of index conoloscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRC-related mortality rate</measure>
    <time_frame>15 years</time_frame>
    <description>the rate of mortality due to CRC-related incidents</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Colorectal Neoplasia</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Normal finding</arm_group_label>
    <description>Colonoscopy finding normal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperplastic polyps</arm_group_label>
    <description>Colonoscopy finding of hyperplastic polyps</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-risk adenomas</arm_group_label>
    <description>Colonoscopy finding of low-risk adenomas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-risk adenomas</arm_group_label>
    <description>Colonoscopy finding of high-risk adenomas</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We will identify patients from CDARS with colonoscopy performed from 1 January 2000 to 31&#xD;
        October 2020. Other relevant diagnoses, procedures, concomitant drugs, laboratory&#xD;
        parameters and pathology results will be retrieved and studied.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. All patients with colonoscopy performed in HA hospitals during the study period would be&#xD;
        eligible for screening.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Patients with documented personal history of colorectal cancers before the study period&#xD;
        would be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Felix Sia</last_name>
    <phone>+85226370428</phone>
    <email>felix.sia@cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thomas Lam</last_name>
    <phone>+85226370428</phone>
    <email>thomas.lam@cuhk.edu.hk</email>
  </overall_contact_backup>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Louis Ho Shing Lau</investigator_full_name>
    <investigator_title>Resident Specialist</investigator_title>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There are no plans to share IPD with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

